Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

BMC Cancer

Table 4 What factors are important in your decision to participate in a clinical trialNumber (%) of patients who agree/strongly agree to survey questions grouped by demographic characteristics of interest

	Age		Health Status		Cancer Status
Question	n/N (%) < 75 n/N (%) ≥ 75	p-value	n/N (%) Good/Excellent n/N (%) Poor/Marginal/Ave	p-value	n/N (%) Cured n/N (%) Not Cured	p-value
Recommendation from cancer doctor to participate	45/46 (98) 44/47 (94)		45/47 (96) 41/43 (95)		30/31 (97) 46/49 (94)
		0.32		0.93		0.56
Recommendation from the family doctor to participate	36/46 (78) 40/46 (87)		38/47 (81) 35/42 (83)		25/31 (81) 39/48 (81)
		0.27		0.76		0.95
Recommendation from family/friends to participate	26/46 (57) 26/45 (58)		24/49 (49) 23/39 (59)		17/31 (55) 28/47 (60)
		0.90		0.35		0.68
The chance that you may live longer because of the treatment	43/46 (93) 40/46 (87)		41/47 (87) 39/42 (93)		24/31 (77) 46/48 (96)
		0.29		0.38		0.012
The chance that you may feel better because of the treatment	44/46 (96) 44/46 (96)		45/47 (96) 40/42 (95)		30/31 (97) 45/48 (94)
		1.00		0.91		0.55
The chance that this study may help other cancer patients in the future	44/45 (98) 43/46 (93)		44/46 (96) 40/42 (95)		30/31 (97) 44/47 (94)
		0.32		0.93		0.54
Your age	31/44 (70) 28/46 (61)		29/45 (64) 28/42 (67)		20/30 (67) 29/47 (62)
		0.34		0.83		0.66

ISSN: 1471-2407